Ophthalmology · Leawood, KS
NPI
1215925987
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
11261 Nall Ave
Leawood, KS, 66211
Phone (913) 261-2023
Groups this clinician bills Medicare through
Medicare paid, 2024
$385K
5,397 services
Medicare patients, 2024
1,532
Average age 76
Drug cost, 2024
$840K
7,875 prescriptions
Company payments, 2025
$488
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin P Pikey was code 92133 (computerized ophthalmic imaging), 921 times for 910 patients. In total Kevin P Pikey billed 5,397 services in 32 codes, and Medicare paid $385K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92133 Computerized Ophthalmic Imaging | Office | 921 | 910 | $22.17 | $20K |
| 92083 Vision, Hearing, and Speech Services | Office | 900 | 880 | $40.56 | $37K |
| 99213 Office E&M - Established | Office | 770 | 592 | $57.67 | $44K |
| 92014 Ophthalmological E&M | Office | 699 | 672 | $74.82 | $52K |
| 99214 Office E&M - Established | Office | 560 | 554 | $78.56 | $44K |
| 92012 Ophthalmological E&M | Office | 361 | 319 | $57.59 | $21K |
| 92136 Ultrasound - Nonspecific | Office | 223 | 124 | $25.23 | $5,627 |
| 66984 Cataract Surgery | Facility | 185 | 108 | $377.18 | $70K |
| 92020 Ophthalmological E&M | Office | 99 | 96 | $18.68 | $1,849 |
| 76514 Ultrasound - Nonspecific | Office | 89 | 89 | $7.35 | $654 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Facility | 77 | 48 | $141.74 | $11K |
| 92012 Ophthalmological E&M | Facility | 71 | 54 | $29.76 | $2,113 |
| 92004 Ophthalmological E&M | Office | 58 | 58 | $95.98 | $5,567 |
| 66821 Cataract Surgery | Office | 50 | 37 | $235.35 | $12K |
| 92014 Ophthalmological E&M | Facility | 40 | 40 | $37.00 | $1,480 |
By year: 2022 $434K for 5,865 services; 2023 $426K for 5,606 services; 2024 $385K for 5,397 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin P Pikey prescribed most often to Medicare patients was Latanoprost, with 2,649 prescriptions and refills. In total Kevin P Pikey wrote 7,875 Medicare prescriptions that cost $840K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,649 | 6,590 | 835 | $40K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,016 | 2,218 | 277 | $14K |
| Prednisolone Acetate Generic | 631 | 856 | 339 | $20K |
| Timolol Maleate Generic | 560 | 1,372 | 199 | $7,324 |
| Lumigan Bimatoprost | 518 | 1,092 | 152 | $301K |
| Combigan Brimonidine Tartrate/Timolol | 494 | 861 | 111 | $180K |
| Brimonidine Tartrate Generic | 466 | 1,039 | 154 | $10K |
| Ofloxacin Generic | 322 | 335 | 240 | $3,342 |
| Dorzolamide Hcl Generic | 231 | 509 | 73 | $5,235 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 125 | 251 | 46 | $26K |
| Ketorolac Tromethamine Generic | 102 | 128 | 88 | $2,571 |
| Simbrinza Brinzolamide/Brimonidine Tart | 96 | 174 | 26 | $26K |
| Alphagan P Brimonidine Tartrate | 76 | 149 | 22 | $35K |
| Brinzolamide Generic | 67 | 157 | 22 | $14K |
| Loteprednol Etabonate Generic | 46 | 78 | 19 | $9,159 |
Brand drugs: 2,640 claims; generic drugs: 5,235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin P Pikey $488 ($488 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bausch & Lomb Americas Inc. with $286.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 10 | $286 |
| Abbvie Inc. ABBV | 4 | $82.88 |
| Alcon Vision LLC ALC | 4 | $77.7 |
| RxSight Inc RXST | 1 | $23.32 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $18.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.